TY - JOUR
T1 - Treatment modes for EGFR mutations in patients with brain metastases from non-small cell lung cancer
T2 - Controversy, causes, and solutions
AU - Zhuang, Hongqing
AU - Shi, Siyu
AU - Chang, Joe Y.
N1 - Publisher Copyright:
© Translational lung cancer research. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Brain metastasis from non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations is a hot research topic, but also a difficulty in targeted NSCLC therapy, and is also the focus of controversy in the field of lung cancer treatment. According to medical oncology, asymptomatic patients were initially treated with targeted therapy, followed by local radiotherapy when symptoms present or disease progresses. However, from the perspective of the discipline of radiotherapy, brain metastases need to be treated before drug resistance, as it may affect survival. Controversies between disciplines have brought much confusion to the treatment choices of clinicians. We summarized and discussed relevant literatures in this article to seek the truth in providing reference in clinical practice for treating diseases and solving problems.
AB - Brain metastasis from non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations is a hot research topic, but also a difficulty in targeted NSCLC therapy, and is also the focus of controversy in the field of lung cancer treatment. According to medical oncology, asymptomatic patients were initially treated with targeted therapy, followed by local radiotherapy when symptoms present or disease progresses. However, from the perspective of the discipline of radiotherapy, brain metastases need to be treated before drug resistance, as it may affect survival. Controversies between disciplines have brought much confusion to the treatment choices of clinicians. We summarized and discussed relevant literatures in this article to seek the truth in providing reference in clinical practice for treating diseases and solving problems.
KW - Brain metastasis
KW - Epidermal growth factor receptor mutation (EGFR mutation)
KW - Non-small cell lung cancer (NSCLC)
KW - Radiotherapy
KW - Tyrosine kinase inhibitors (TKIs)
UR - http://www.scopus.com/inward/record.url?scp=85072523402&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072523402&partnerID=8YFLogxK
U2 - 10.21037/tlcr.2019.07.03
DO - 10.21037/tlcr.2019.07.03
M3 - Review article
C2 - 31555525
AN - SCOPUS:85072523402
SN - 2218-6751
VL - 8
SP - 524
EP - 531
JO - Translational Lung Cancer Research
JF - Translational Lung Cancer Research
IS - 4
ER -